
Amber Van Laar
Amber Van Laar is a senior vice president of Global Clinical Development at AskBio, where she is involved in advancing innovative therapies for neurological conditions, including Parkinson's disease. With extensive experience in clinical research, she focuses on developing novel treatments aimed at halting disease progression and improving the quality of life for patients living with Parkinson's.
Power14,968
Reach235,925
Country presence
Recent news mentions
Amber Van Laar is a senior vice president, Global Clinical Development, AskBio.
Parkinson's is becoming more common. Here are 5 things everyone should knowFox News·
United States· 2026-09-13




